Integrated Advisors Network LLC Buys 277 Shares of CME Group Inc. (NASDAQ:CME)

Integrated Advisors Network LLC increased its stake in CME Group Inc. (NASDAQ:CME) by 26.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,317 shares of the financial services provider’s stock after purchasing an additional 277 shares during the quarter. Integrated Advisors Network LLC’s holdings in CME Group were worth $291,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Pallas Capital Advisors LLC bought a new stake in CME Group during the third quarter valued at about $1,633,000. Hunter Associates Investment Management LLC raised its holdings in CME Group by 6.3% during the third quarter. Hunter Associates Investment Management LLC now owns 1,094 shares of the financial services provider’s stock valued at $242,000 after acquiring an additional 65 shares during the period. Nisa Investment Advisors LLC raised its holdings in CME Group by 10.1% during the third quarter. Nisa Investment Advisors LLC now owns 112,259 shares of the financial services provider’s stock valued at $24,770,000 after acquiring an additional 10,302 shares during the period. Pullen Investment Management LLC raised its holdings in CME Group by 1.8% during the third quarter. Pullen Investment Management LLC now owns 7,229 shares of the financial services provider’s stock valued at $1,595,000 after acquiring an additional 128 shares during the period. Finally, Capital Advisors Ltd. LLC raised its holdings in CME Group by 4.9% during the third quarter. Capital Advisors Ltd. LLC now owns 1,251 shares of the financial services provider’s stock valued at $276,000 after acquiring an additional 58 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Trading Down 0.8 %

CME opened at $223.61 on Friday. The firm has a market cap of $80.52 billion, a P/E ratio of 23.51, a P/E/G ratio of 5.72 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a 50-day moving average of $220.69 and a 200 day moving average of $209.46.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the business posted $2.25 earnings per share. The firm’s revenue was up 18.4% on a year-over-year basis. As a group, research analysts forecast that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Analysts Set New Price Targets

CME has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Piper Sandler raised their price target on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Keefe, Bruyette & Woods lifted their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft lifted their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Finally, Oppenheimer lifted their target price on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and an average target price of $222.73.

Insider Buying and Selling at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,221 shares of company stock worth $3,351,895 over the last 90 days. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.